Methanesulfonyl fluoride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethanesulfonyl fluoride
Drug Alias NameSNX-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSenexta
China Registration ClassN/A

Develop Information

Active CompaniesSenexta
Inactive CompaniesSenexta Therapeutics Sa
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A